Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia.

Takashi WadaEri MusoShoichi MaruyamaAkinori HaraKengo FuruichiKenichi YoshimuraMariko MiyazakiEiichi SatoMasanori AbeYugo ShibagakiIchiei NaritaHitoshi YokoyamaNoriko MoriYukio YuzawaTakeshi MatsubaraTatsuo TsukamotoJun WadaTakafumi ItoKosuke MasutaniKazuhiko TsuruyaShoichi FujimotoAkihiro TsudaHitoshi SuzukiKenji KasunoYoshio TeradaTakeshi NakataNoriaki IinoShuzo Kobayashi

Published in: Clinical and experimental nephrology (2017)

This study will determine the effectiveness and safety of LDL apheresis for diabetic nephropathy patients with severe proteinuria and dyslipidemia.

Keyphrases

diabetic nephropathy
clinical trial
early onset
randomized controlled trial
open label
phase ii
study protocol
drug induced
low density lipoprotein
double blind
phase iii